Articoli con mandati relativi all'accesso pubblico - Busquets OUlteriori informazioni
Non disponibili pubblicamente: 10
Long-term exposition to a high fat diet favors the appearance of β-amyloid depositions in the brain of C57BL/6J mice. A potential model of sporadic Alzheimer’s disease
O Busquets, M Ettcheto, M Pallàs, C Beas-Zarate, E Verdaguer, ...
Mechanisms of ageing and development 162, 38-45, 2017
Mandati: Government of Spain
Epigallocatechin-3-Gallate (EGCG) improves cognitive deficits aggravated by an obesogenic diet through modulation of unfolded protein response in APPswe/PS1dE9 mice
M Ettcheto, A Cano, PR Manzine, O Busquets, E Verdaguer, ...
Molecular neurobiology 57, 1814-1827, 2020
Mandati: Government of Spain
Early preclinical changes in hippocampal CREB-binding protein expression in a mouse model of familial Alzheimer’s disease
M Ettcheto, S Abad, D Petrov, I Pedrós, O Busquets, E Sánchez-López, ...
Molecular neurobiology 55, 4885-4895, 2018
Mandati: Government of Spain
JNK1 inhibition by Licochalcone A leads to neuronal protection against excitotoxic insults derived of kainic acid
O Busquets, M Ettcheto, E Verdaguer, RD Castro-Torres, C Auladell, ...
Neuropharmacology 131, 440-452, 2018
Mandati: Government of Spain
Peripheral and central effects of memantine in a mixed preclinical mice model of obesity and familial Alzheimer’s disease
M Ettcheto, E Sánchez-López, Y Gómez-Mínguez, H Cabrera, O Busquets, ...
Molecular Neurobiology 55, 7327-7339, 2018
Mandati: US National Institutes of Health, Government of Spain
A chronological review of potential disease-modifying therapeutic strategies for alzheimer's disease
M Ettcheto, O Busquets, T Espinosa-Jiménez, E Verdaguer, C Auladell, ...
Current Pharmaceutical Design 26 (12), 1286-1299, 2020
Mandati: Government of Spain
c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments
O Busquets, M Ettcheto, À Eritja, T Espinosa-Jiménez, E Verdaguer, ...
Journal of Molecular Medicine 97, 1723-1733, 2019
Mandati: Government of Spain
The preclinical discovery and development of opicapone for the treatment of Parkinson’s disease
M Ettcheto, O Busquets, E Sanchez-Lopez, A Cano, PR Manzine, ...
Expert Opinion on Drug Discovery 15 (9), 993-1003, 2020
Mandati: Government of Spain
Role of brain c‐Jun N‐terminal kinase 2 in the control of the insulin receptor and its relationship with cognitive performance in a high‐fat diet pre‐clinical model
O Busquets, A Eritja, BM Lopez, M Ettcheto, PR Manzine, ...
Journal of Neurochemistry 149 (2), 255-268, 2019
Mandati: Government of Spain
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
A Camins, M Ettcheto, O Busquets, PR Manzine, RD Castro-Torres, ...
Expert Opinion on Investigational Drugs 28 (1), 93-97, 2019
Mandati: Government of Spain
Disponibili pubblicamente: 25
Memantine for the treatment of dementia: a review on its current and future applications
J Folch, O Busquets, M Ettcheto, E Sánchez-López, RD Castro-Torres, ...
Journal of Alzheimer's Disease 62 (3), 1223-1240, 2018
Mandati: US National Institutes of Health, Government of Spain
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker
PR Manzine, M Ettcheto, A Cano, O Busquets, E Marcello, S Pelucchi, ...
Biomedicine & Pharmacotherapy 113, 108661, 2019
Mandati: Government of Spain
Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia
M Ettcheto, J Olloquequi, E Sanchez-Lopez, O Busquets, A Cano, ...
Frontiers in aging neuroscience 11, 344, 2020
Mandati: Government of Spain
The implication of the brain insulin receptor in late onset Alzheimer’s disease dementia
J Folch, M Ettcheto, O Busquets, E Sanchez-Lopez, RD Castro-Torres, ...
Pharmaceuticals 11 (1), 11, 2018
Mandati: Government of Spain
The involvement of peripheral and brain insulin resistance in late onset Alzheimer’s dementia
J Folch, J Olloquequi, M Ettcheto, O Busquets, E Sanchez-Lopez, A Cano, ...
Frontiers in aging neuroscience 11, 236, 2019
Mandati: Government of Spain
Experimental models for aging and their potential for novel drug discovery
J Folch, O Busquets, M Ettcheto, E Sánchez-López, M Pallàs, ...
Current Neuropharmacology 16 (10), 1466-1483, 2018
Mandati: US National Institutes of Health, Government of Spain
Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
M Ettcheto, E Sánchez-López, L Pons, O Busquets, J Olloquequi, ...
Redox biology 13, 345-352, 2017
Mandati: Government of Spain
JNK isoforms are involved in the control of adult hippocampal neurogenesis in mice, both in physiological conditions and in an experimental model of temporal lobe epilepsy
RD Castro-Torres, J Landa, M Rabaza, O Busquets, J Olloquequi, ...
Molecular Neurobiology 56, 5856-5865, 2019
Mandati: Government of Spain
Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration
C Auladell, L de Lemos, E Verdaguer, M Ettcheto, O Busquets, ...
Front Biosci (Landmark Ed) 22, 795-814, 2017
Mandati: Government of Spain
A metabolic perspective of late onset Alzheimer’s disease
M Ettcheto, A Cano, O Busquets, PR Manzine, E Sanchez-Lopez, ...
Pharmacological Research 145, 104255, 2019
Mandati: US National Institutes of Health, Government of Spain
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software